Evaluation of infliximab as second-line treatment of acute graft versus host disease -validating response on day 7 and 28 as predictors of survival.
| Image |  |
|---|---|
| Description | scientific article published in February 2018 |
| Author/s |
author: Marietta Nygaard Henrik Sengeløv |
| Publication date | February 1, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |